GlassScriptPhysician profile
Michael-Paul Stetson
NPI 1831740554
$1,792.94
in general payments reported to CMS, 2019-2025
19 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $370 · 2023: $576 · 2024: $463 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $492.83 | 2022-2024 | Jelmyto |
| Procept Biorobotics Corporation | $189.34 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $165.22 | 2022-2025 | |
| Boston Scientific Corporation | $142.90 | 2024-2025 | Ams 700, Rezum Generator |
| Tolmar, INC. | $118.11 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $111.14 | 2024-2025 | Keytruda |
| 180 Medical, INC. | $91.91 | 2022-2024 | |
| Myriad Genetic Laboratories, INC. | $62.62 | 2024 | Myrisk, Prolaris |
| Janssen Biotech, INC. | $62.12 | 2025 | Erleada |
| Urovant Sciences INC | $54.94 | 2022 | |
| Sumitomo Pharma America, INC. | $52.14 | 2023-2024 | Orgovyx |
| Endo USA, INC. | $41.57 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $36.99 | 2024-2025 | Itind System |
| Axonics, INC. | $36.34 | 2023-2024 | Axonics, Bulkamid |
| C. R. Bard, INC. & Subsidiaries | $35.69 | 2025 | Bard Urinary Drainage Bag |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $32.35 | 2022 | |
| Tempus Ai, INC | $31.59 | 2025 | Xt Cdx |
| Kowa Pharmaceuticals America, INC. | $20.08 | 2023 | Seglentis |
| Tolmar Pharmaceuticals, INC. | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael-Paul Stetson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.